Body and Brain vs AKT

Body and Brain is the stronger play right now because its FDD is current (2026 vs. AKT’s overdue 2024 filing), which removes a major deal-killing friction. For a software vendor selling into franchisors, stale disclosure means the prospect’s unit economics, royalty structure, and supplier mandates are unverifiable—that stalls budget conversations and erodes trust. Body and Brain’s CURRENT filing lets you walk in with hard numbers: 67 total units, 20 franchised, a 10 % royalty, and an explicit approved-supplier procurement model. That procurement model is the terrain advantage—it signals the franchisor controls the tech stack, so your POS or marketing automation pitch lands on a decision-maker who can mandate adoption, not just recommend it.

The tradeoff is TAM. AKT likely has more units and higher AUV (we don’t have the figures, but fitness brands of that scale usually do), so the long-term license pool is bigger. But Body and Brain’s -5.6 % unit growth is a yellow flag, not a red one: a shrinking network still has 20 franchised doors that need scheduling, back-office, and marketing tools today, and the 10 % royalty means the franchisor is motivated to drive per-unit revenue—which software can directly lift. Timing matters more than absolute size when you’re selling into a compliance-driven cycle. An overdue FDD means AKT is effectively off the table until they refile; Body and Brain is ready to engage now.

Verdict: Body and Brain wins on timing and procurement clarity, which outweighs AKT’s probable larger TAM while its filing stays overdue.